Amgen’s quarterly results top expectations despite Enbrel sales decline
Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues dropped for one of its ...
Read moreAmgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues dropped for one of its ...
Read moreIonis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for ...
Read moreWuxi XDC Cayman’s shares rose in their trading debut in Hong Kong as investors scrambled to compensate for the lost ...
Read moreFTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
Read moreEli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to ...
Read moreGilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations, with weaker ...
Read moreThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or ...
Read moreDrug maker Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or ...
Read moreAmgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as ...
Read morePfizer Inc. PFE, -1.30% is in talks to acquire biotech Seagen Inc. SGEN, -0.51%, according to people familiar with the matter, the latest ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline